A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
Clinical trial NCT05460273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05460273
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2023-11-07
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.